Sponsor Pipeline

Zhuhai Trinomab Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-28 NCT07347938
A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for…		 Recruitment opened
2026-07-28 NCT07347938
A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for…		 Primary endpoint(s) modified
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07107932 A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following Injury Tetanus Recruiting
NCT07347938 A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for… Tetanus Recruiting
Get alerts when Zhuhai Trinomab Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free